Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1996 Sep 15;155(6):772–775.

"Drug may have caused huge number of deaths": lessons learned during an encounter with The Fifth Estate.

M G Myers
PMCID: PMC1335251  PMID: 8823222

Abstract

A recent television program raised questions about how the media deal with complex medical issues. In this case, concerns about the safety of nifedipine and other calcium-channel blockers became the subject of an investigative report for a television program, which alleged that many patients were dying because of these drugs. The program prompted numerous calls to family physicians by patients concerned about the safety of their antihypertensive medications. Cardiologist Martin Myers believes the scientific community should respond when it believes reporting on medical and scientific issues has been biased and inaccurate.

Full text

PDF
775

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Furberg C. D., Psaty B. M., Meyer J. V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995 Sep 1;92(5):1326–1331. doi: 10.1161/01.cir.92.5.1326. [DOI] [PubMed] [Google Scholar]
  2. Myers M. G., Baigrie R. S., Dubbin J. D. Nifedipine versus propranolol treatment for unstable angina in the elderly. Can J Cardiol. 1988 Nov-Dec;4(8):402–406. [PubMed] [Google Scholar]
  3. Myers M. G., Carruthers S. G., Leenen F. H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ. 1989 May 15;140(10):1141–1146. [PMC free article] [PubMed] [Google Scholar]
  4. Myers M. G., Leenen F. H., Burns R., Frankel D. Nifedipine tablet vs. hydralazine in patients with persisting hypertension who receive combined diuretic and beta-blocker therapy. Clin Pharmacol Ther. 1986 Apr;39(4):409–413. doi: 10.1038/clpt.1986.63. [DOI] [PubMed] [Google Scholar]
  5. Myers M. G., Leenen F. H., Tanner J. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass. Am J Hypertens. 1995 Jul;8(7):712–718. doi: 10.1016/0895-7061(95)00117-8. [DOI] [PubMed] [Google Scholar]
  6. Myers M. G. New drugs for hypertension: should data precede conclusions? CMAJ. 1990 Aug 15;143(4):265–267. [PMC free article] [PubMed] [Google Scholar]
  7. Myers M. G., Toal C. B. Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. The Switch Study Investigators. Can J Cardiol. 1995 Nov;11(10):913–917. [PubMed] [Google Scholar]
  8. Ogilvie R. I., Burgess E. D., Cusson J. R., Feldman R. D., Leiter L. A., Myers M. G. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. CMAJ. 1993 Sep 1;149(5):575–584. [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES